VB

Vishwanathreddy Basavantraya Patil

Active Director Director DIN 11243945
DIN 11243945 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishwanathreddy Basavantraya Patil

Data last updated:

Vishwanathreddy Basavantraya Patil is a Director at Cutie Science Pharmaceutical Private Limited (since 2025).

DIN 11243945
Primary Designation Director
First Appointment 14 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20252025Active

Board colleagues of Vishwanathreddy Basavantraya Patil

NameDINCompanyDesignation
Basavantraya11243944Cutie Science Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cutie Science Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vishwanathreddy Basavantraya Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishwanathreddy Basavantraya Patil

Vishwanathreddy Basavantraya Patil currently holds 1 directorship: Cutie Science Pharmaceutical Private Limited (Director, since 14 Aug 2025).

Vishwanathreddy Basavantraya Patil was first appointed on 14 Aug 2025 as Director at Cutie Science Pharmaceutical Private Limited.

The current boards of Vishwanathreddy Basavantraya Patil's companies include Basavantraya (Cutie Science Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available